# Topical Interferon Gamma-1b for Central Serous Chorioretinopathy

> **NCT01468337** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 5 (actual)

## Conditions studied

- Retinal Disease
- Macular Disease

## Interventions

- **DRUG:** Interferon gamma-1b

## Key facts

- **NCT ID:** NCT01468337
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-11
- **Final completion:** 2014-02
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2024-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01468337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01468337, "Topical Interferon Gamma-1b for Central Serous Chorioretinopathy". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01468337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*